» Articles » PMID: 16397737

Comparative Study on Osteoconductivity by Synthetic Octacalcium Phosphate and Sintered Hydroxyapatite in Rabbit Bone Marrow

Overview
Specialty Pathology
Date 2006 Jan 7
PMID 16397737
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Octacalcium phosphate (OCP) is thought to be a precursor of the mineral crystals in biological apatite. Synthetic OCP has been shown to be converted into an apatite structure when implanted in murine calvarial bone, to enhance bone regeneration more than synthetic hydroxyapatite (HA), and to degrade faster than biodegradable beta-tricalcium phosphate. This study was designed to investigate whether OCP implantation enhances the formation and resorption of new bone (remodeling) concomitant with OCP degradation when implanted intramedullary in a rabbit femur for 12 weeks, compared to sintered HA ceramic. Histological and histomorphometric analyses using undecalcified specimens showed that the area of bone apposition was significantly higher on OCP than on HA between 2 and 3 weeks, whereas it subsequently became smaller on OCP than on HA. The area attacked by multinucleated giant cells, including tartrate-resistant acid phosphatase (TRAP)-positive cells, was significantly higher for OCP than for HA at 8 weeks. Radiography revealed resorption of OCP but not of HA. The results disclose some osteoconductive characteristics of synthetic OCP in the bone marrow space: (1) enhancement of bone regeneration at the initial bone apposition stage and (2) stimulation of resorption of the newly formed bone coupled with OCP biodegradation mediated by TRAP-positive osteoclast-like cells. These results suggest that synthetic OCP would be a more useful bone substitute than HA in implant applications where rapid bone formation and concomitant implant resorption are important considerations.

Citing Articles

Enhanced osteogenic capacity of octacalcium phosphate involving adsorption of stromal-derived factor-1 in a standardized defect of a rat femur.

Kanabuchi R, Hamai R, Mori Y, Hamada S, Shiwaku Y, Sai Y J Mater Sci Mater Med. 2025; 36(1):23.

PMID: 40019693 PMC: 11870905. DOI: 10.1007/s10856-025-06872-9.


Advances in Bioceramics for Bone Regeneration: A Narrative Review.

Brochu B, Sturm S, Kawase De Queiroz Goncalves J, Mirsky N, Sandino A, Panthaki K Biomimetics (Basel). 2024; 9(11).

PMID: 39590262 PMC: 11592113. DOI: 10.3390/biomimetics9110690.


Biocompatible nanocomposite hydroxyapatite-based granules with increased specific surface area and bioresorbability for bone regenerative medicine applications.

Trzaskowska M, Vivcharenko V, Benko A, Franus W, Goryczka T, Barylski A Sci Rep. 2024; 14(1):28137.

PMID: 39548237 PMC: 11568164. DOI: 10.1038/s41598-024-79822-0.


Calcium Citrate Amount and Gelatine Source Impact on Hydroxyapatite Formation in Bone Regeneration Material in Simulated Body Fluid.

Wang Y, Yokoi T, Shimabukuro M, Kawashita M Molecules. 2024; 29(16).

PMID: 39203002 PMC: 11357162. DOI: 10.3390/molecules29163925.


Functionalization of Octacalcium Phosphate Bone Graft with Cisplatin and Zoledronic Acid: Physicochemical and Bioactive Properties.

Kuvshinova E, Petrakova N, Nikitina Y, Sviridova I, Akhmedova S, Kirsanova V Int J Mol Sci. 2023; 24(14).

PMID: 37511391 PMC: 10380611. DOI: 10.3390/ijms241411633.